Health care company says Trump tariffs will cost it $60M–$70M this year

Baxter International may face significant financial losses this year due to President Trump's tariffs, with estimates suggesting between $60 million and $70 million in costs. Baxter's executive vice president, Joel Grade, revealed during an earnings call that while some of their products are made domestically, international procurement exposes the company to tariffs. Despite these challenges, Baxter, known for its IV fluid bags among other pharmaceuticals, has mitigated some impacts but remains vulnerable as the U.S. faces trade tensions with China and other nations.